229 related articles for article (PubMed ID: 30531139)
21. Successful Treatment with Cyclosporin A in Tocilizumab-resistant TAFRO Syndrome.
Yamaga Y; Tokuyama K; Kato T; Yamada R; Murayama M; Ikeda T; Yamakita N; Kunieda T
Intern Med; 2016; 55(2):185-90. PubMed ID: 26781021
[TBL] [Abstract][Full Text] [Related]
22. TAFRO Syndrome with Disseminated Intravascular Coagulation Successfully Treated with Tocilizumab and Recombinant Thrombomodulin.
Takayama Y; Kubota T; Ogino Y; Ohnishi H; Togitani K; Yokoyama A
Intern Med; 2018 May; 57(9):1291-1296. PubMed ID: 29279488
[TBL] [Abstract][Full Text] [Related]
23. Renal thrombotic microangiopathy associated with multicentric Castleman's disease. Report of two cases.
Lajoie G; Kumar S; Min KW; Silva FG
Am J Surg Pathol; 1995 Sep; 19(9):1021-8. PubMed ID: 7661275
[TBL] [Abstract][Full Text] [Related]
24. [HHV-8-positive Castleman's disease with rapidly progressing multiorgan failure mimicking TAFRO syndrome].
Ide S; Ohara S; Uchida T; Inoue M; Hagihara M
Rinsho Ketsueki; 2020; 61(10):1497-1501. PubMed ID: 33162447
[TBL] [Abstract][Full Text] [Related]
25. TAFRO Syndrome with Renal Thrombotic Microangiopathy: Insights into the Molecular Mechanism and Treatment Opportunities.
Tu KH; Fan PY; Chen TD; Chuang WY; Wu CY; Ku CL; Tian YC; Yang CW; Fang JT; Yang HY
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208103
[TBL] [Abstract][Full Text] [Related]
26. An Autopsy Case of TAFRO Syndrome with Type II Respiratory Failure.
Wada M; Nagata A; Kawashima A; Kagawa K
Am J Case Rep; 2020 Oct; 21():e926721. PubMed ID: 33048915
[TBL] [Abstract][Full Text] [Related]
27. [TAFRO syndrome showing cholangitis on liver biopsy].
Nagai Y; Ando S; Honda N; Noguchi H; Maemori M; Hayashi T; Sakai H
Rinsho Ketsueki; 2016; 57(12):2490-2495. PubMed ID: 28090015
[TBL] [Abstract][Full Text] [Related]
28. Pathological findings of progressive renal involvement in a patient with TAFRO syndrome.
Saito H; Tanaka K; Fujiwara M; Iwasaki T; Numata T; Oda A; Kanno M; Tanaka M; Eiro M; Satoh M; Kazama JJ
CEN Case Rep; 2019 Nov; 8(4):239-245. PubMed ID: 31077056
[TBL] [Abstract][Full Text] [Related]
29. Japanese variant of multicentric castleman's disease associated with serositis and thrombocytopenia--a report of two cases: is TAFRO syndrome (Castleman- Kojima disease) a distinct clinicopathological entity?
Masaki Y; Nakajima A; Iwao H; Kurose N; Sato T; Nakamura T; Miki M; Sakai T; Kawanami T; Sawaki T; Fujita Y; Tanaka M; Fukushima T; Okazaki T; Umehara H
J Clin Exp Hematop; 2013; 53(1):79-85. PubMed ID: 23801138
[TBL] [Abstract][Full Text] [Related]
30. Successful treatment of a Caucasian case of multifocal Castleman's disease with TAFRO syndrome with a pathophysiology targeted therapy - a case report.
Tedesco S; Postacchini L; Manfredi L; Goteri G; Luchetti MM; Festa A; Gabrielli A; Pomponio G
Exp Hematol Oncol; 2015; 4(1):3. PubMed ID: 25671135
[TBL] [Abstract][Full Text] [Related]
31. Membranous nephropathy associated with multicentric Castleman's disease that was successfully treated with tocilizumab: a case report and review of the literature.
Saiki R; Katayama K; Hirabayashi Y; Oda K; Fujimoto M; Murata T; Nakajima A; Dohi K
BMC Nephrol; 2021 Jun; 22(1):216. PubMed ID: 34107915
[TBL] [Abstract][Full Text] [Related]
32. Tocilizumab for the treatment of TAFRO syndrome: a systematic literature review.
Akiyama M; Kaneko Y; Takeuchi T
Ann Hematol; 2020 Nov; 99(11):2463-2475. PubMed ID: 32964342
[TBL] [Abstract][Full Text] [Related]
33. Successful rituximab treatment of TAFRO syndrome with pathological findings of glomerular endothelial damage.
Noda Y; Saka Y; Kato A; Mimura T; Naruse T
Clin Nephrol Case Stud; 2018; 6():16-20. PubMed ID: 30009125
[TBL] [Abstract][Full Text] [Related]
34. Fatal case of TAFRO syndrome associated with over-immunosuppression: a case report and review of the literature.
Matsuhisa T; Takahashi N; Nakaguro M; Sato M; Inoue E; Teshigawara S; Ozawa Y; Kondo T; Nakamura S; Sato J; Ban N
Nagoya J Med Sci; 2019 Aug; 81(3):519-528. PubMed ID: 31579342
[TBL] [Abstract][Full Text] [Related]
35. Successfully treated multicentric Castleman's disease with renal thrombotic microangiopathy using rituximab and corticosteroid.
Lee JP; Kim DK; Oh DY; Paik JH; Moon KC; Kim S; Kim YS
Clin Nephrol; 2011 Feb; 75(2):165-70. PubMed ID: 21255547
[TBL] [Abstract][Full Text] [Related]
36. The first report of adolescent TAFRO syndrome, a unique clinicopathologic variant of multicentric Castleman's disease.
Kubokawa I; Yachie A; Hayakawa A; Hirase S; Yamamoto N; Mori T; Yanai T; Takeshima Y; Kyo E; Kageyama G; Nagai H; Uehara K; Kojima M; Iijima K
BMC Pediatr; 2014 Jun; 14():139. PubMed ID: 24890946
[TBL] [Abstract][Full Text] [Related]
37. A life-threatening case of TAFRO syndrome with dramatic response to tocilizumab, rituximab, and pulse steroids: The first case report in Latin America.
José FF; Kerbauy LN; Perini GF; Blumenschein DI; Pasqualin DDC; Malheiros DMAC; Campos Neto GC; de Souza Santos FP; Piovesan R; Hamerschlak N
Medicine (Baltimore); 2017 Mar; 96(13):e6271. PubMed ID: 28353560
[TBL] [Abstract][Full Text] [Related]
38. Renal thrombotic microangiopathy in a patient with septic disseminated intravascular coagulation.
Sakamaki Y; Konishi K; Hayashi K; Hashiguchi A; Hayashi M; Kubota E; Saruta T; Itoh H
BMC Nephrol; 2013 Nov; 14():260. PubMed ID: 24279773
[TBL] [Abstract][Full Text] [Related]
39. A severe case of thrombocytopenia, anasarca, fever, renal insufficiency or reticulin fibrosis, and organomegaly syndrome with myocardial and skeletal muscle calcification despite hypocalcemia: a case report.
Minomo S; Fujiwara Y; Sakashita S; Takamura A; Nagata K
J Med Case Rep; 2021 Jan; 15(1):3. PubMed ID: 33402219
[TBL] [Abstract][Full Text] [Related]
40. TAFRO syndrome: A case report and review of the literature.
Hou T; Dhillon J; Xiao W; Jaffe ES; Sands AM; Neppalli V; Deeb G; Zhang N
Hum Pathol (N Y); 2017 Nov; 10():1-4. PubMed ID: 31608209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
